GeoVax Labs reported Q4 2024 revenue of $864.4K, missed analyst consensus of $2.4M by $1.5M. Diluted EPS came in at $-0.30, beat the $-0.79 consensus by $0.49.
Trailing eight quarters through Q4 2024
Common questions about GeoVax Labs's Q4 2024 earnings report.
GeoVax Labs (GOVX) reported Q4 2024 earnings on March 27, 2025 after market close.
GeoVax Labs reported revenue of $864.4K and diluted EPS of $-0.30 for Q4 2024.
Revenue missed the consensus estimate of $2.4M by $1.5M. EPS beat the consensus estimate of $-0.79 by $0.49.
You can read the 10-K periodic report (0001437749-25-009614) directly on SEC EDGAR. The filing index links above go to sec.gov.